the growing role of mrd as a clinical endpoint in cll
Published 1 year ago • 78 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:59
the role of mrd as a prognostic & predictive biomarker in cll
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
1:59
the expanding role of mrd in cll
-
2:37
allo-hsct for cll in the era of novel agents
-
6:16
allogeneic stem cell transplant: kat's story
-
2:26
how does cll progress? understanding the stages of cll
-
24:36
mrd in aml: what is it and what do i do about it?
-
1:58
the future role of mrd measurement in cll
-
1:19
the prognostic value of mrd in cll
-
0:44
the clinical meaning of mrd below the threshold of mcr in aml
-
2:13
cll at a genomic level
-
1:29
future research into mrd-guided treatment of cll
-
1:40
mrd as a marker for depth of remission in cll
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
3:33
the growing role of machine learning in hematological oncology
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
2:34
real-world data and mrd in cll
-
8:33
boven regimen for previously untreated cll: long-term follow-up and mrd kinetics
-
0:49
extending survival in patients with cll: novel agents, mrd, and overcoming rt
-
6:17
the progression and evolution of cll: mechanisms and therapies
-
0:54
the role of allogeneic stem cell transplantation in cll